National Capital Consortium Infectious Disease

Topics

• Mosquito-borne diseases and control 250
• HIV Research and Treatment 152
• Antibiotic Resistance in Bacteria 107
• SARS-CoV-2 and COVID-19 Research 96
• Escherichia coli research studies 92
• RNA Interference and Gene Delivery 91
• Malaria Research and Control 82
• Travel-related health issues 74
• Viral Infections and Outbreaks Research 67
• Research on Leishmaniasis Studies 60
• Respiratory viral infections research 57
• Antimicrobial Resistance in Staphylococcus 52

Most cited

1. CAR T cells produced in vivo to treat cardiac injury.

   Science (New York, N.Y.) · 2022 · 1,131 citations · Drew Weissman

2. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

   Nature reviews. Drug discovery · 2021 · 1,165 citations · Drew Weissman

3. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026.

   Critical care medicine · 2026 · 81 citations · Ryan Maves

4. In vivo chimeric antigen receptor (CAR)-T cell therapy.

   Nature reviews. Drug discovery · 2026 · 85 citations · Drew Weissman

5. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

   The New England journal of medicine · 2021 · 698 citations · Stephen Thomas

6. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026.

   Intensive care medicine · 2026 · 45 citations · Ryan Maves

7. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.